Breast-Conserving Therapy for Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 180
Special Issue Editor
Special Issue Information
Dear Colleagues,
The modern management of breast cancer consists of a multidisciplinary approach, including systemic and locoregional treatments. Considerable advances have been made in the surgical treatment, with the development of new techniques that have improved the aesthetic outcomes in patients submitted to breast-conserving surgery or mastectomy. Nonetheless, breast conservation should be the preferred choice when technically feasible, since it is linked to better outcomes in terms of quality of life, cosmetic satisfaction, and psychological well-being when compared to mastectomy with immediate or delayed reconstruction. More importantly, recent large studies enlightened that patients undergoing breast-conserving surgery plus radiation therapy may have better survival outcomes than those who undergo mastectomy.
In this Special Issue, original research articles and reviews are welcome that address the topic of breast conservation in the multidisciplinary management of breast cancer. The main goal is to highlight the new insights that have emerged in breast- conservative treatment in relation to recent clinical, biological and epidemiological studies on breast cancer.
Research areas may include (but are not limited to) the following:
- Survival advantages of breast-conserving therapy over mastectomy.
- Advances in external radiotherapy after breast conservation surgery.
- Systemic effects of radiation therapy in patients undergoing breast conservative surgery.
- Intraoperative radiotherapy (IORT)
- Intraoperative localization of nonpalpable breast cancers.
- Oncoplastic surgery in patients receiving breast conservation.
- Trends in mastectomy and breast-conserving surgery in different world regions.
- Interactions between immune system and surgical trauma.
- Psychological benefits of breast conservation in patients with breast cancer.
- Breast-conserving surgery in young patients with breast cancer.
- Breast-conserving surgery in luminal breast cancer.
- Breast-conserving surgery in triple-negative and HER2-positive breast cancer.
- Redo breast-conserving surgery in patients with locoregional recurrence.
- Breast-conserving surgery in patients with multifocal/multicentric disease.
- Breast-conserving surgery after neoadjuvant chemotherapy.
- Breast-conserving surgery in the prophylactic or curative treatment in germline mutation carriers.
- Role of multidisciplinary team in the decision-making process of surgical treatment.
I look forward to receiving your contributions.
Dr. Alessandro Fancellu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast-conserving therapy
- mastectomy
- survival outcomes
- radiotherapy
- oncoplastic surgery
- chemotherapy
- molecular subtypes
